MABVAX THERAPEUTICS HLDGS IN's ticker is MBVXQ and the CUSIP is 55414P702. A total of 1 filers reported holding MABVAX THERAPEUTICS HLDGS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Bay Advisors LLC | 23 | $1,000 | 0.00% |